XOMAP XOMA posts massive Q4 2025 earnings beat but shares fall 144 percent in todays trading GBTG Global far exceeds fourth quarter 2025 EPS estimates posts modest share gains today Moderna Inc MRNA Counterparty Arbutus Biopharma Secures Regulatory Catalyst Amid Settled LNP Licensing Agreement